Mr. Áron Mészáros | Health Professions | Research Excellence Award
Hungarian University of Sport Science | Hungary
1
1
2
Citations
h-index
Documents
Featured Publications
Topological Methods in Nonlinear Analysis | Journal Article · 2025 ·
Hungarian University of Sport Science | Hungary
Citations
h-index
Documents
University of Bari “Aldo Moro” – University Hospital “Policlinico di Bari” | Italy
Prof. Gianna DiPalma is an accomplished clinician-scientist and academic specializing in dentistry, oral surgery, orthodontics, and regenerative medicine. With dual qualifications in Dentistry (DDS, 2000) and Medicine and Surgery (MD, 2020) from the University of Bari “Aldo Moro,” she has established a distinguished career bridging clinical practice, scientific innovation, and higher education. She further completed an international PhD program in Clinical Dentistry, conducted in collaboration with New York University (USA) and the Eastman Dental Institute (UK), followed by advanced postgraduate training in implant prosthodontics and oral surgical specialization. Her academic trajectory includes an international doctoral fellowship at the University of Lyon, France, reinforcing her international scientific profile. Prof. DiPalma has contributed extensively to oral health sciences, with research spanning regenerative dentistry, biomaterials, implantology, growth factor–based tissue repair, pediatric dentistry, and digital orthodontics. She has authored scientific publications, book chapters, and conference works, and serves as a reviewer and guest editor for internationally indexed journals, including Scopus- and PubMed-listed platforms. Her research involvement includes participation in competitive national and international projects, particularly those focusing on tissue engineering, stem cells, and translational dentistry. Her work demonstrates significant interdisciplinary relevance across dental medicine, biomedical engineering, and clinical innovation. Throughout her career, she has received more than 30 national and international awards recognizing academic merit, research contribution, and innovation in clinical dentistry. She has also contributed to the advancement of dental education through extensive teaching roles, postgraduate training supervision, and invited lectures across Europe and beyond. Prof. DiPalma’s contributions continue to support evidence-based innovations that improve patient care, guide clinical protocols, and enhance the global development of regenerative and digital dental sciences. Her academic trajectory reflects sustained research productivity, international collaboration, and a growing societal impact within the fields of oral health and medical sciences.
Buthelezi, K., Kibirige, D. M. K., & Buthelezi-Dube, N. N. (2025). The evolution of methods and tools used to assess soil health indicators: A scoping review. SSRN.
Buthelezi-Dube, N. N., & Sithole, Z. (2025). Acidification-driven soil phosphorus fractionation following long-term fertilization and cessation at Ukulinga mesic grassland in South Africa. Scientific Reports.
Buthelezi, K., & Buthelezi-Dube, N. (2025). Long-term effects of nitrogen and lime application on plant–microbial interactions and soil carbon stability in a semi-arid grassland. Plants.
Leshalagae, M., & Buthelezi-Dube, N. N. (2023). Impact of topsoil mining for unfired mudbricks on soil quality in eastern KwaZulu-Natal, South Africa. Land Degradation & Development.
Vilakazi, S. P., Muchaonyerwa, P., & Buthelezi-Dube, N. N. (2023). Characteristics and liming potential of biochar types from potato waste and pine-bark. PLOS ONE
The Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University Spinal Surgery Group | China
Dr. Dujiang Yang is currently pursuing his graduate studies in Traditional Chinese Medicine (Orthopedics and Traumatology) at Southwest Medical University (September 2023–June 2026). Despite being in training, he has already established an exceptionally prolific academic record, demonstrating strong research capability and outstanding scientific productivity. As the first author, he has published 43 English SCI-indexed papers, one Chinese Peking University Core article, several regular English journal papers, and additional Chinese publications. His cumulative SCI impact factor as first author has reached 264.5, reflecting both depth and influence in interdisciplinary biomedical research. His publications span top-tier journals including Annals of the Rheumatic Diseases (IF=20.6), Journal of Extracellular Vesicles (IF=14.5), Advanced Science (IF=14.3), Leukemia (IF=13.4), Cardiovascular Research (IF=13.2), Angiogenesis (IF=9.2), British Journal of Pharmacology (IF=7.7), and many others across fields such as immunology, degenerative diseases, oncology, tissue engineering, and stem cell therapies. His research interests are broad yet cohesive, focusing on molecular mechanisms of disease, regenerative medicine, biomaterials, single-cell analysis, and translational therapeutic strategies. In addition to research articles, he has also contributed multiple commentary papers in SCI journals, including a notable commentary in JAMA Network Open (IF=9.7). Beyond published work, Yang also has several manuscripts under review or accepted, including research utilizing multi-omics approaches, machine learning, network pharmacology, UHPLC-Q-Orbitrap-ESI-MS, and spatial transcriptomics, further demonstrating advanced methodological skills and translational vision. His work—ranging from tendon repair, osteoarthritis treatment, muscle regeneration, virology, to stem cell-based therapy—reflects a rare integration of modern biomedical science with traditional Chinese medicine perspectives. Yang has actively contributed to multiple funded scientific research projects under the supervision of Professor Guoyou Wang. His roles include project design, experimental execution, and manuscript preparation. Key projects include: a National Natural Science Foundation project exploring mechanisms of Shaoyang Shenggu prescription in regulating IL-17/NF-κB pathways to inhibit chondrocyte senescence; and several Sichuan Provincial research grants focused on network pharmacology, TGF-β/GPX4 signaling, iron-death mechanisms, and therapeutic evaluation of traditional herbal approaches in knee osteoarthritis.
Profile: ORCID
(2025). Navigating the complex landscape of DPP4 inhibition in inflammation: From novel mechanisms to unresolved translational challenges. Inflammation Research.
(2025). USP5-laden ApoEVs and E2F1 stabilization in disc repair: Unresolved questions on senescence, specificity and endosomal escape. Journal of Extracellular Vesicles.
(2025). Advancing the tendinopathy triad: Comment on “Tendinopathy: The interplay between mechanical stress, inflammation, and vascularity”. Advanced Science.
(2025). Time to move beyond treatment initiation: Implementing risk-stratified therapy in fracture liaison services. Osteoporosis International.
Fondation Adolphe de Rothschild Hospital | France
Dr. Aurore Sajust de Bergues de Escalup is a radiology resident specializing in advanced neuroimaging, thoracic imaging, and musculoskeletal diagnostic modalities, with a growing research portfolio in artificial intelligence–enhanced medical imaging. She is currently completing the advanced phase of her radiology residency at the Hôpital Fondation Adolphe de Rothschild, focusing on neuroradiology and head-and-neck imaging, while simultaneously advancing her research interests in biomedical image analysis and quantitative MRI. Dr. Sajust de Bergues de Escalup holds a Master’s degree in Biomedical Engineering (BioImaging Specialization), awarded with honors, and completed at the PARCC laboratory (Inserm UMR 970). She was awarded the Année Recherche scholarship (ARS), supporting her contributions to translational imaging research. Her academic foundation includes competitive rankings in French national medical examinations (PACES rank: 52; ECN rank: 1227) and early international scientific exposure through her participation in the Biomed Research Academy at the University of Pennsylvania. Her recent peer-reviewed publications reflect an interdisciplinary approach combining clinical expertise and innovation. These include studies on synthetic MRI for optic nerve pathology, deep learning–based MRI reconstruction techniques, and CT phenotypes of interstitial lung disease in autoimmune disorders. Collectively, her work contributes to improving diagnostic accuracy, reducing scan times, and advancing precision imaging in ophthalmologic and thoracic conditions. Her collaborations span multiple major French academic hospitals, including Hôpital Robert-Debré, Hôpital Henri-Mondor, Hôpital Bichat, and the Hôpital de la Timone. Fluent in French and English, she has developed both clinical and research experience across pediatric radiology, emergency imaging, cardiothoracic radiology, and uro-gynecological imaging. Her long-term vision is to contribute to the integration of artificial intelligence and quantitative imaging biomarkers to enhance clinical decision-making and improve patient outcomes in neuroradiology and systemic disease evaluation.
Profile: ORCID
Sajust de Bergues de Escalup, A., Lecler, A., Poirion, É., Papeix, C., Deschamps, R., Milea, D., Savatovsky, J., Duron, L., & O’Shaughnessy, E. (2025). Deep learning-based image reconstruction significantly improves image quality of MRI examinations of the orbit at 3 Tesla. Diagnostic and Interventional Imaging.
Sajust de Bergues de Escalup, A., Duron, L., Koskas, P., Poirion, É., Papeix, C., Deschamps, R., Milea, D., O’Shaughnessy, E., Savatovsky, J., Fournier, L., et al. (2025). Synthetic MRI for detecting abnormal signals in the optic nerves. Investigative Radiology
School of Allied Health Sciences,Vinayakamissions Research Foundation-DU | India
Prof. Dr. B. Sendilkumar is a distinguished academic leader and healthcare quality expert with more than 22 years of experience spanning higher education management, hospital administration, public health systems, and accreditation frameworks. He currently serves as the Dean of the Faculty of Allied Health Sciences at Vinayaka Mission’s Research Foundation (VMRF-DU), where he oversees more than twenty undergraduate and postgraduate programs across multiple campuses and steers institutional planning, governance, and quality enhancement initiatives. Dr. Sendilkumar holds advanced degrees including a Ph.D. in Health Sciences, M.Phil. in Hospital & Health Systems Management, MBA in Hospital Management, and MPH, complementing his foundational training as a Bachelor of Dental Surgery (BDS). A certified NABH Internal Assessor, CII SR EHS Assessor, and Six Sigma Black Belt, he is an accredited ISO Lead Auditor for ISO 9001:2015, ISO 21001:2018, ISO 14001:2015, and ISO 45001:2018, with extensive auditing exposure in both healthcare and higher education institutions. As Dean, he has played a pivotal role in leading his institution to multiple national recognitions, including ARIIA rankings, IIC 4-star rating, WASH certification, ISO 21001:2018 QCI approval, and several prestigious education awards. Under his leadership, the institution has achieved numerous milestones in innovation, community engagement, digital learning, and accreditation. His administrative influence also extends to the VIMS Hospital, where he significantly contributed to securing NABH Pre-Accreditation and strengthening clinical governance, infection control, and quality management systems. Dr. Sendilkumar’s professional footprint includes active involvement in CII committees, global academic societies, and public health organizations, reflecting his commitment to capacity building and policy-level contributions. He has mentored numerous students, guided research projects, facilitated international collaborations, and promoted technology-enabled education through global platforms. His work continues to advance healthcare quality, institutional excellence, and community-oriented public health practices, marking him as a highly respected academic and administrative professional in India’s higher education and healthcare sectors.
Selvan, S. T., Chandrasekaran, R., Muthusamy, S., Balasundaram, S., & Ramamurthy, D. (2024).
Eco-technological method for carbon dioxide biosorption and molecular mechanism of the RuBisCO enzyme from unicellular microalga Chlorella vulgaris RDS03: A synergistic approach. Biomass Conversion and Biorefinery.
Selvan, S. T., Muthusamy, S., Chandrasekaran, R., Ramamurthy, D., & Balasundaram, S. (2024).
Modeling and dynamic design of an artificial culture medium for heterotrophic cultivation of Tetradesmus obliquus RDS01 for CO₂ sequestration and green biofuels production: An eco-technological approach. Biomass Conversion and Biorefinery.
Tamilchudar, R., Sendilkumar, B., & Srividhya, K. (2024).
Assessment of knowledge and attitude of Allied Health Sciences students regarding depression among patients. Biosciences Biotechnology Research Asia.
Balasundaram, S., Raju, T., Natesan, M., & Syamalakumari, L. K. (2024).
Trends in budget allocation for primary healthcare: A decadal perspective on prioritization in Tamil Nadu. International Journal of Community Medicine and Public Health.
Tamilchudar, R., Arivuchudar, R., & Sendilkumar, B. (2024).
Elucidating the impact of anemia and nutrition education on the accommodative disorder of eye among the college students. Biosciences Biotechnology Research Asia.
Institute of Emergency and Critical Care Medicine | Taiwan
Dr. Huang Hsien-Hao is an accomplished researcher and academic whose work spans advanced materials science, nanotechnology, and interdisciplinary engineering innovation. His scholarly contributions reflect a strong commitment to addressing global challenges through high-impact research, technological development, and international collaboration. Over the course of his career, Dr. Huang has established an impressive academic record, authoring numerous peer-reviewed publications in leading scientific journals and contributing to several book chapters and conference proceedings. His publications collectively demonstrate a consistent trajectory of innovation, with a citation profile that underscores the significance and global recognition of his work. Dr. Huang’s research expertise primarily focuses on functional materials, nanoscale fabrication, and the integration of advanced materials into biomedical, environmental, and energy-related applications. His work often bridges fundamental scientific principles with real-world applications, enabling solutions that enhance performance, sustainability, and societal well-being. Through his leadership in multidisciplinary projects, Dr. Huang has collaborated extensively with international research institutions, industry partners, and government-funded programs, contributing to breakthroughs in material performance, device efficiency, and next-generation engineering approaches. In recognition of his research excellence, Dr. Huang has received multiple awards, competitive grants, and professional honors. His contributions have not only advanced the academic understanding of his field but have also led to practical outcomes with wide-ranging societal impact, including improved material systems, enhanced diagnostic and therapeutic technologies, and environmentally conscious engineering solutions. He has also supervised graduate researchers, fostering the next generation of scientists and contributing to global scientific capacity building. Dr. Huang continues to play an influential role in the international scientific community through editorial duties, peer-review service, and active participation in conferences and professional societies. His ongoing work reflects a dedication to scientific advancement, innovation-driven research, and meaningful contributions to society.
Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China
Dr. Bo Wan is an emerging clinician–scientist in the field of ophthalmology, recognized for his strong commitment to advancing clinical practice and research related to myopia, cataract, and retinal disorders. With several years of experience as an ophthalmologist in a leading medical institution, he has developed extensive competence in the diagnosis, management, and surgical treatment of common and complex ocular diseases. His clinical work is characterized by precision, rigorous reasoning, and patient-centered decision-making, contributing to improved visual outcomes and enhanced quality of life for diverse patient populations. In parallel with his clinical responsibilities, Dr. Wan has maintained an active engagement in academic research, focusing on evidence-based approaches to ophthalmic disorders and exploring strategies for disease prevention and early intervention. He has authored 2 scholarly documents, which together have received 19 citations and an h-index of 1, reflecting the early but growing influence of his research contributions. His work demonstrates a consistent interest in the integration of clinical insights with scientific inquiry, and he has collaborated with colleagues across medical and academic settings to advance shared research goals. These collaborations have supported the development of multidisciplinary perspectives that enrich both clinical practice and investigative rigor. Dr. Wan’s scholarly activities reflect a broader commitment to public health and societal benefit. By contributing to improved diagnostic accuracy and more effective therapeutic pathways in ophthalmology, his work supports long-term visual health and addresses the rising global challenges of myopia and age-related ocular diseases. He is dedicated to continuous professional development and intends to expand his research output, strengthen international collaborations, and contribute to high-impact studies that can influence global ophthalmic guidelines and clinical standards. With a strong foundation in clinical practice, disciplined research habits, and a clear vision for future growth, Dr. Bo Wan is well positioned to make meaningful and sustained contributions to ophthalmic science and global eye health.
Profile: Scopus
Hangzhou Dalton Biosciences Ltd | China
Prof. Dr. Shaobing Hua is a distinguished biomedical scientist and innovator whose career spans more than three decades of impactful contributions to molecular biology, therapeutic antibody discovery, and advanced diagnostic technologies. Trained as a molecular biologist with postdoctoral experience at leading U.S. research institutions, he has played a pivotal role in translating fundamental discoveries into clinically deployable solutions. His early work advanced the understanding of signal transduction, proteasome regulation, and gene expression in protozoan parasites, laying the foundation for subsequent research in therapeutic antibody platforms, which led to multiple U.S. and international patents for novel humanized antibodies and high-throughput screening methods. Prof. Hua is widely recognized for developing next-generation hybrid capture technologies and innovative HPV testing platforms that have transformed cervical cancer screening, particularly in resource-limited settings. Under his scientific leadership, DALTON BioSciences has introduced a suite of diagnostic products for cervical cancer, endometrial carcinoma, pre-eclampsia, and vaginitis, contributing to the health of nearly 30 million women. His portfolio includes over 30 peer-reviewed publications in journals such as Journal of Biological Chemistry, Clinical Cancer Research, Protein Science, and Oncogene, and several dozens of patents granted in the United States, China, and the PCT system. His work has been cited widely by researchers across molecular diagnostics, oncology, and immunotechnology. Throughout his career, Prof. Hua has collaborated extensively with major clinical institutions, including leading hospitals affiliated with Zhejiang University, Peking University, the Chinese Academy of Medical Sciences, and several provincial oncology centers. He has served in key roles in national research programs, including China’s 863 Program, national key research plans, and major public health initiatives focused on cervical cancer elimination. His contributions have significantly advanced women’s health diagnostics, strengthened public health infrastructures, and accelerated the global adoption of innovative molecular screening technologies. Prof. Hua’s research, leadership, and translational impact continue to shape the future of precision diagnostics and global health innovation.
Profile: ORCID
Liu, S., Han, B., Jin, D. Q., Li, L. W., Ge, T. T., Shou, Y. J., Ye, J. M., Zhang, L., & Hua, S. B. (2025). Design and development of a target amplification-free microfluidic platform for multiplex nucleic acids detection: A new generation of hybrid capture immunoassay. Journal of Medical Virology.
Ding, L., Lin, Y. H., Azam, M., Sheridan, J., Wei, S., Gupta, G., Singh, R. K., Pauling, M. H., Chu, A., Tran, A., Yu, N., Hu, J., Wang, W., Long, H., Xiang, D., Zhu, L., & Hua, S. B. (2010). Generation of high-affinity fully human anti-human interleukin-8 antibodies from its cDNA by two-hybrid screening and affinity maturation in yeast. Protein Science, 19, 1957–1966.
Vaday, G. G., Hua, S. B., Peehl, D. M., Pauling, M. H., Lin, Y. H., Zhu, L., Lawrence, D. M., Foda, H. D., & Zucker, S. (2004). CXCR4 and CXCL12 (SDF-1) in prostate cancer: Inhibitory effects of human single-chain Fv antibodies. Clinical Cancer Research, 10, 5630–5639.
Xia, C., Ma, W., Wang, F., Hua, S. B., & Liu, M. (2001). Identification of a prostate-specific G-protein coupled receptor in prostate cancer. Oncogene, 20, 5903–5907.
Xia, C., Bao, Z., Tabassam, F., Ma, W., Qiu, M., Hua, S. B., & Liu, M. (2000). GCIP, a novel human Grap2 and Cyclin D interacting protein, regulates E2F-mediated transcriptional activity. Journal of Biological Chemistry, 275, 20942–20948.
Humanitas Castelli, Italy